Abstract
This review summarizes the authors’ studies in the past decade
aimed at developing a synthetic oligosaccharide-based glycoconjugate
vaccine to prevent a serious human disease caused by the Gram negative
bacterium Shigella dysenteriae type 1.
Starting from simple monosaccharides, oligosaccharides as large
as a 24 monosaccharide-containing linear polymer, were assembled.
Under suitable conditions, oligosaccharides containing 4 to 16 hexopyranose
residues were covalently attached to an immunogenic protein. The
serum response to the synthetic glycoconjugates depends, both on
the size of the oligosaccharides, and on the molar ratio of the
oligosaccharides to the carrier protein. Also reviewed are studies
of the fine specificities of the interaction between oligosaccharides
and anti-polysaccharide monoclonal antibodies as well as conformational
studies of the synthetic oligosaccharides.
1 Polysaccharide-Based Vaccines
1.1 Surface Polysaccharides of Bacteria
1.2 Immunologic Properties of Polysaccharides
1.3 Polysaccharide-Protein Conjugates
1.3.1 Methods for the Conjugation of Polysaccharides
to Proteins
1.3.2 Immunogenicity of Polysaccharide-Protein Conjugates
1.4 Synthetic Oligosaccharides Can be Superior to Natural Polysaccharides
for Glycoconjugate Vaccines
1.5 Potentials of the O-Specific Polysaccharides of Shigellae for Vaccine Development
2 Chemical Synthesis of Oligosaccharides Related to
theS.
dysenteriae Type 1
2.1 General Strategy
2.2 Synthesis of the Monosaccharide Building Blocks
2.2.1 The l -Rhamnose Moiety
2.2.2 The d -Galactose Moiety
2.2.3 The d -Glucosamine Synthons
2.3 Synthesis of a Complete Repeating Unit
2.4 Construction of Extended Oligosaccharides
2.5 The Lipophilic Protecting Group-Based Approach to
3 Covalent Attachment of the Oligosaccharides to Human
3.1 Conjugation through a Secondary Spacer, Using Reductive Amination
3.2 Conjugation through Diels-Alder Cycloaddition
Reactions
4 The Molecular Specificity of the Non-Covalent Binding
5 Conformational Studies
6 Immunogenicity of the Protein Conjugates of the Synthetic
7 Conclusions and Future Prospects
Key words
polysaccharide - oligosaccharides - monosaccharides - antibodies
References
<A NAME="RA31402ST-1">1 </A> For a concise overview of polysaccharide-based antibacterial
vaccines and a review of oligosaccharide-protein conjugates as vaccine
candidates see:
Pozsgay V.
Adv. Carbohydr.
Chem. Biochem.
2001,
56:
153
<A NAME="RA31402ST-2">2 </A>
Robbins JB.
Schneerson R.
Anderson P.
Smith DH.
J. Am. Med. Assoc.
1996,
276:
1181
<A NAME="RA31402ST-3">3 </A>
Sutton A.
Schneerson R.
Kendallmorris S.
Robbins JB.
Infect. Immun.
1982,
35:
95
<A NAME="RA31402ST-4">4 </A>
Liang-Takasaki CJ.
Grossman N.
Leive L.
J. Immunol.
1983,
130:
1867
<A NAME="RA31402ST-5">5 </A>
Robbins JB.
Chu C.
Schneerson R.
Clin.
Infect. Dis.
1992,
15:
346
<A NAME="RA31402ST-6">6 </A>
Robbins JB.
Schneerson R.
Szu SC.
J.
Infect. Dis.
1995,
171:
1387
<A NAME="RA31402ST-7">7 </A>
Fothergill LD.
Wright J.
J. Immunol.
1933,
24:
273
<A NAME="RA31402ST-8">8 </A>
Goldschneider I.
Gotschlich EC.
Artenstein MS.
J. Exp. Med.
1969,
129:
1307
<A NAME="RA31402ST-9">9 </A>
Schneerson R.
Robbins JB.
N: Engl. J. Med.
1975,
292:
1093
<A NAME="RA31402ST-10">10 </A>
Robbins JB.
Schneerson R.
Glode MP.
Vann WF.
Schiffer MS.
Liu T.-Y.
Parke JC.
Huntley C.
J. Allergy
Clin. Immunol.
1975,
56:
141
<A NAME="RA31402ST-11">11 </A>
Robbins JB.
Schneerson R.
Gotschlich EC.
Pediatr. Infect.
Dis. J.
2000,
19:
945
<A NAME="RA31402ST-12">12 </A>
Landsteiner K.
The Specificity of Serological Reactions
Harvard
University Press;
Cambridge MA:
1945.
<A NAME="RA31402ST-13">13 </A>
Goebel WF.
Avery OT.
J. Exp. Med.
1929,
50:
521
<A NAME="RA31402ST-14">14 </A>
Goebel WF.
J.
Exp. Med.
1939,
69:
353
<A NAME="RA31402ST-15">15 </A>
Goebel WF.
J.
Exp. Med.
1940,
72:
33
<A NAME="RA31402ST-16">16 </A>
Peeters CCAM.
Lagerman PR.
de Weers O.
Ooemn LA.
Hoogerhout P.
Beurret M.
Poolman JT. In Vaccine Protocols
Robinson A.
Farrar G.
Wiblin C.
Humana Press Inc.;
Totowa
N.J.:
1996.
p.111-133
<A NAME="RA31402ST-17">17 </A>
Dick WE.
Beurret M.
Contrib.
Microbiol. Immunol.
1989,
10:
48
<A NAME="RA31402ST-18">18 </A>
Jennings HJ.
Sood R. In K. Neoglycoconjugates. Preparation
and Applications
Lee YC.
Lee RT.
Academic
Press;
New York:
1994.
p.325-371
<A NAME="RA31402ST-19">19 </A>
Chu C.
Liu B.
Watson D.
Szu S.
Bryla D.
Shiloach J.
Schneerson R.
Robbins JB.
Infect.
Immun.
1991,
59:
4450
<A NAME="RA31402ST-20">20 </A>
Bethell GS.
Ayers JS.
Hancock WS.
Hearn MTW.
J.
Biol. Chem.
1979,
254:
2572
<A NAME="RA31402ST-21">21 </A>
Marburg S.
Jorn D.
Tolman RL.
Arison B.
McCauley J.
Kniskern PJ.
Hagopian A.
Vella PP.
J. Am. Chem. Soc.
1986,
108:
5282
<A NAME="RA31402ST-22">22 </A>
Egan W.
Ann.
Rep. Med. Chem.
1993,
28:
257
<A NAME="RA31402ST-23">23 </A>
Gray GR.
Arch.
Biochem. Biophys.
1974,
163:
426
<A NAME="RA31402ST-24">24 </A>
Paoletti LC.
Kasper DL.
Michon F.
DiFabio JL.
Holme K.
Jennings HJ.
Wessels M.
J.
Biol. Chem.
1990,
265:
18278
<A NAME="RA31402ST-25">25 </A>
Paulsen H.
Paal M.
Carbohydr. Res.
1983,
113:
203
<A NAME="RA31402ST-26">26 </A>
Roy R.
Katzenellenbogen E.
Jennings HJ.
Can.
J. Biochem. Cell Biol.
1984,
62:
270
<A NAME="RA31402ST-27">27 </A>
Liu XC.
Dordick JS.
J. Am. Chem. Soc.
1999,
121:
466
<A NAME="RA31402ST-28">28 </A>
Constantino P.
Viti S.
Podda A.
Velmonte MA.
Nencioni L.
Rappuoli R.
Vaccine
1992,
10:
691
<A NAME="RA31402ST-29">29 </A>
Arakatsu Y.
Ashwell G.
Kabat EA.
J.
Immunol.
1966,
97:
858
<A NAME="RA31402ST-30">30 </A>
Schneerson R.
Barrera O.
Sutton A.
Robbins JB.
J. Exp. Med.
1980,
152:
361
<A NAME="RA31402ST-31">31 </A>
Black S.
Shinefield H.
Fireman B.
Lewis E.
Ray P.
Hansen JR.
Elvin L.
Ensor KM.
Hackell J.
Siber G.
Malinoski F.
Madore D.
Chang I.
Kohberger R.
Watson W.
Austrian R.
Edwards K.
Pediatr.
Infect. Dis. J.
2000,
19:
187
<A NAME="RA31402ST-32">32 </A>
Lagergard T.
Shiloach J.
Robbins JB.
Schneerson R.
Infect. Immun.
1990,
58:
687
<A NAME="RA31402ST-33">33 </A>
Lin FYC.
Ho VA.
Khiem HB.
Trach DD.
Bay PV.
Thanh TC.
Kossaczka Z.
Bryla DA.
Shiloach J.
Robbins JB.
Schneerson R.
Szu SC.
Lanh MN.
Hunt S.
Trinh L.
Kaufman JB.
N.
Engl. J. Med.
2001,
344:
1263
<A NAME="RA31402ST-34">34 </A>
Shinefield H.
Black S.
Fattom A.
Horwith G.
Rasgon S.
Ordonez J.
Yeoh H.
Law D.
Robbins JB.
Schneerson R.
Muenz L.
Naso R.
N.
Engl. J. Med.
2002,
346:
491
<A NAME="RA31402ST-35">35 </A>
Svenson SB.
Lindberg AA.
Infect. Immun.
1981,
32:
490
<A NAME="RA31402ST-36">36 </A>
Anderson PW.
Pichichero ME.
Insel RA.
Betts R.
Eby R.
Smith DH.
J. Immunol.
1986,
137:
1181
<A NAME="RA31402ST-37">37 </A>
Laferriere CA.
Sood RK.
deMuys JM.
Michon F.
Jennings HJ.
Vaccine
1997,
15:
179
<A NAME="RA31402ST-38">38 </A>
Pichichero ME.
Porcelli S.
Treanor J.
Anderson P.
Vaccine
1998,
16:
83
<A NAME="RA31402ST-39">39 </A>
Glaudemans CPJ.
Chem. Rev.
1991,
91:
25
<A NAME="RA31402ST-40">40 </A>
Lindberg AA.
Pal T.
Vaccine
1993,
11:
168
<A NAME="RA31402ST-41">41 </A>
Iversen ER.
Colding H.
Petersen L.
Ngetich R.
Shanks GD.
Trans.
R. Soc. Trop. Med. Hyg.
1998,
92:
30
<A NAME="RA31402ST-42">42 </A>
Iwalokun BA.
Gbenle GO.
Smith SI.
Ogunledun A.
Akinsinde KA.
Omonigbehin EA.
J.
Health Popul. Nutr.
2001,
19:
183
<A NAME="RA31402ST-43">43 </A>
Lindberg AA.
Karnell A.
Weintraub A.
Rev.
Infect. Dis.
1991,
13:
S279
<A NAME="RA31402ST-44">44 </A>
Passwell JH.
Harlev E.
Ashkenazi S.
Chu CY.
Miron D.
Ramon R.
Farzan N.
Shiloach J.
Bryla DA.
Majadly F.
Roberson R.
Robbins JB.
Schneerson R.
Infect.
Immun.
2001,
69:
1351
<A NAME="RA31402ST-45">45 </A>
Konadu EY.
Lin FYC.
Ho VA.
Thuy NTT.
Bay PV.
Thanh TC.
Khiem HB.
Trach DD.
Karpas AB.
Li J.
Bryla DA.
Robbins JB.
Szu SC.
Infect. Immun.
2000,
68:
1529
<A NAME="RA31402ST-46">46 </A>
Pozsgay V.
Angew.
Chem. Int. Ed.
1998,
37:
138
<A NAME="RA31402ST-47">47 </A>
Pozsgay V.
J.
Org. Chem.
1998,
63:
5983
<A NAME="RA31402ST-48">48 </A>
Pozsgay V.
Coxon B.
Yeh H.
Bioorg.
Med. Chem.
1993,
1:
237
<A NAME="RA31402ST-49">49 </A>
Pozsgay V.
Pannell L.
Carbohydr. Res.
1994,
258:
105
<A NAME="RA31402ST-50">50 </A>
Pozsgay V.
Glaudemans CPJ.
Robbins JB.
Schneerson R.
Carbohydr.
Res.
1993,
244:
259
<A NAME="RA31402ST-51">51 </A>
Pozsgay V.
J.
Am. Chem. Soc.
1995,
117:
6673-6681
<A NAME="RA31402ST-52">52 </A>
Pozsgay V.
Tetrahedron:
Asymmetry
2000,
11:
151
<A NAME="RA31402ST-53">53 </A>
Pozsgay V.
Coxon B.
Carbohydr. Res.
1994,
257:
189
<A NAME="RA31402ST-54">54 </A>
Pozsgay V.
Jennings HJ.
Carbohydr. Res.
1988,
179:
61
<A NAME="RA31402ST-55">55 </A>
Schmidt RR.
Jung K.-H. In Carbohydrates in Chemistry and
Biology
Vol 1:
Ernst B.
Hart GW.
Sinaӱ P.
Wiley-VCH;
Weinheim:
2000.
p.5-59
<A NAME="RA31402ST-56">56 </A>
Pozsgay V.
Glaudemans CPJ.
Robbins JB.
Schneerson R.
Tetrahedron
1992,
48:
10249
<A NAME="RA31402ST-57">57 </A>
Pozsgay V.
J.
Org. Chem.
1999,
64:
7277
<A NAME="RA31402ST-58">58 </A>
Pozsgay V.
J.
Carbohydr. Chem.
2001,
71:
659
<A NAME="RA31402ST-59">59 </A>
Pedretti V.
Veyrières A.
Sinaӱ P.
Tetrahedron
1990,
46:
77
<A NAME="RA31402ST-60">60 </A>
Evans ME.
Parrish FW.
Carbohydr. Res.
1977,
54:
105
<A NAME="RA31402ST-61">61 </A> For a comprehensive review of
solid phase-based oligosaccharide synthesis, see:
Solid Support Oligosaccharide Synthesis and
Combinatorial Carbohydrate Libraries
Seeberger PH.
Wiley-Interscience;
New
York:
2002.
<A NAME="RA31402ST-62">62 </A>
Anonymous referee 2002.
<A NAME="RA31402ST-63">63 </A>
Pozsgay V.
Org.
Lett.
1999,
1:
477
<A NAME="RA31402ST-64">64 </A>
Berkin, A.; Pozsgay, V. In preparation.
<A NAME="RA31402ST-65">65 </A>
Vaino AR.
Szarek WA.
Adv. Carbohydr. Chem. Biochem.
2001,
56:
9
<A NAME="RA31402ST-66">66 </A>
Pozsgay V.
Vieira NE.
Yergey A.
Org.
Lett.
2002,
4:
3191
<A NAME="RA31402ST-67">67 </A>
Hudlicky T.
Koszyk FJ.
Kutchan TM.
Sheth JP.
J. Org.
Chem.
1980,
45:
5020
<A NAME="RA31402ST-68">68 </A>
Pavliak V.
Nashed EM.
Pozsgay V.
Kovac P.
Karpas A.
Chu CY.
Schneerson R.
Robbins JB.
Glaudemans CPJ.
J. Biol. Chem.
1993,
268:
25797
<A NAME="RA31402ST-69">69 </A>
Miller CE.
Karpas A.
Schneerson R.
Huppi K.
Kovac P.
Pozsgay V.
Glaudemans CP.
J.
Molec. Immun.
1996,
33:
1217
<A NAME="RA31402ST-70">70 </A>
Pozsgay V.
Glaudemans CPJ.
Robbins JB.
Schneerson R.
Bioorg.
Med. Chem. Lett.
1992,
2:
255
<A NAME="RA31402ST-71">71 </A>
Pozsgay V.
Sari N.
Coxon B.
Carbohydr.
Res.
1998,
308:
229
<A NAME="RA31402ST-72">72 </A>
Coxon B.
Sari N.
Batta G.
Pozsgay V.
Carbohydr. Res.
2000,
324:
53
<A NAME="RA31402ST-73">73 </A>
Nyholm P.-G.
Mulard LA.
Miller CE.
Olin R.
Glaudemans CPJ.
Glycocobiology
2001,
11:
945
<A NAME="RA31402ST-74">74 </A>
Pozsgay V.
Chu C.
Pannell L.
Wolfe J.
Robbins JB.
Schneerson R.
Proc. Natl. Acad. Sci. U.S.A.
1999,
96:
5194
